Search research articles
Contact Us
Filters
Showing results (211-220 of 386) with videos related to
Page
of 39
Sort By:
Neuro-Oncology
|
March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Radhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Frontiers in Neurology
|
February 14, 2022
T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas
Tracy L Luks, Javier E Villanueva-Meyer, Christina Weyer-Jamora, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors
Susan M Chang, Wendy Seiferheld, Walter Curran, et al.
Cancer Discovery
|
September 27, 2019
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation
Lin Wang, Husam Babikir, Sören Müller, et al.
Journal of Neuro-Oncology
|
June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
Nancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression
Christina L Appin, Chibo Hong, Abigail K Suwala, et al.
Investigational New Drugs
|
July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
Susan M Chang, Patrick Wen, Timothy Cloughesy, et al.
Neuro-Oncology
|
May 21, 2026
Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma
Brooke C Braman, Martha A Cady, Allison A Merz-Herrala, et al.
Journal of Neuro-Oncology
|
August 26, 2009
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
Sean M McBride, Daniel A Perez, Mei-Yin Polley, et al.
Neuro-Oncology
|
December 10, 2023
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort
Joshua A Budhu, Ugonma N Chukwueke, Sadhana Jackson, et al.
Page
of 39
Search research articles
Search
Showing results (211-220 of 386) with videos related to
Sort By:
Page
of 39
Neuro-Oncology
|
March 14, 2020
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence
Radhika Mathur, Yalan Zhang, Matthew R Grimmer, et al.
Frontiers in Neurology
|
February 14, 2022
T2 FLAIR Hyperintensity Volume Is Associated With Cognitive Function and Quality of Life in Clinically Stable Patients With Lower Grade Gliomas
Tracy L Luks, Javier E Villanueva-Meyer, Christina Weyer-Jamora, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 6, 2004
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors
Susan M Chang, Wendy Seiferheld, Walter Curran, et al.
Cancer Discovery
|
September 27, 2019
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation
Lin Wang, Husam Babikir, Sören Müller, et al.
Journal of Neuro-Oncology
|
June 14, 2021
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
Nancy Ann Oberheim Bush, Jacob S Young, Yalan Zhang, et al.
Neuro-Oncology
|
December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression
Christina L Appin, Chibo Hong, Abigail K Suwala, et al.
Investigational New Drugs
|
July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
Susan M Chang, Patrick Wen, Timothy Cloughesy, et al.
Neuro-Oncology
|
May 21, 2026
Epidemiological and clinical data link depot medroxyprogesterone acetate to meningioma
Brooke C Braman, Martha A Cady, Allison A Merz-Herrala, et al.
Journal of Neuro-Oncology
|
August 26, 2009
Activation of PI3K/mTOR pathway occurs in most adult low-grade gliomas and predicts patient survival
Sean M McBride, Daniel A Perez, Mei-Yin Polley, et al.
Neuro-Oncology
|
December 10, 2023
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort
Joshua A Budhu, Ugonma N Chukwueke, Sadhana Jackson, et al.
Page
of 39